Unnerved: Molecule that pumps neurons up also keeps them down (Neurodegeneration)

Like a tree that has been chopped down to its roots, damaged nerves often refuse to grow back. Earlier work identified a molecule, myelin-associated glycoprotein (MAG), that impedes a nerve's comeback. MAG's method of delivering the nerve-stunting message--which might keep normal cells from growing out of control--has remained a mystery, however. Now, researchers have pinpointed a cell surface molecule called p75 as the transmitter of MAG's signal. The finding suggests a way to foster nerve regeneration after injury. Although its collaboration with MAG eluded researchers until now, p75 earned fame previously for an opposite role: spurring nerve cell growth. It acts as a receptor, sensing signals outside cells and conveying their messages to the inside. Neurons are covered with the receptor during embryonic development when they begin to reach out to other nerve cells; chemicals called neurotrophins encourage nerves to sprout by goading p75 into action. Three years ago, researchers found that nerve cells doused with neurotrophins overcame MAG's power to squelch growth. To Yamashita and colleagues, the finding hinted at a connection between p75 and MAG. Perhaps MAG has nowhere to go when neurotrophins occupy p75, they reasoned. To learn whether the receptor might be playing both sides--as a growth stimulant and suppressor--the team tested whether MAG requires p75 to relay its message. The researchers examined MAG's effect on nerve elongation in normal mice and in animals lacking the receptor. Without p75, MAG's clout in blocking nerve extension withered. "They demonstrate quite convincingly that p75 has a physiological role in inhibiting nerve growth," says Philip Barker, a molecular neurobiologist at the Montreal Neurological Institute and Hospital in Canada. Next, the researchers looked for conspirators in the molecules' ability to suppress nerve cell extension. They knew that p75's talent for eliciting nerve growth relies on a protein called Rho. When p75 binds neurotrophins, Rho shuts down and nerves branch out. Perhaps p75's nerve-constraining alter ego also relies on Rho, they reasoned. To test the idea, they crippled Rho's function in cells and found that MAG susceptibility vanished. Then they exposed normal and p75-deficient cells to MAG and measured the amount of active Rho. MAG charged up Rho only in the presence of the receptor, verifying p75's part in the game. Further analysis showed that p75 doesn't bind MAG alone. Instead, p75 hooks up with another molecule and the pair sends MAG's nerve-quelling message together. The results are intriguing, "but they raise more questions than they answer," says Marie Filbin, a neurobiologist at Hunter College of the City University of New York. For example, not all nerves produce p75, yet all respond to MAG, suggesting that other receptors might be important. But, Barker predicts that the findings "will have a major impact on the field of neurotrophins" because they uncover a complex role for p75 in neurons. And, he says, they might resolve earlier confusion. Some neurons are known to grow uncontrollably in p75-deficient mice. That observation "might be explained by a lack of MAG-mediated inhibitory signal," Barker adds. What's more, by tweaking p75, scientists might find their green thumb for cultivating degenerated nerves. --Kendall Morgan T. Yamashita, H. Higuchi, M. Tohyama, The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho. J. Cell Biol. 157 , 565-570 (2002). [Abstract] [Full Text]

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.